Skip to content

Performance and biochemical responses in young athletes: Effects of melatonin and caffeine ingestion

Performance and biochemical responses in young athletes: Effects of melatonin and caffeine ingestion .

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202402524926856
Enrollment
16
Registered
2024-02-05
Start date
2023-05-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine

Interventions

CAF supplementation
MEL supplementation
CAF and MEL supplementation
Placebo

Sponsors

Kef regional Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: All participants had to be: - physically active (4 ± 2 h of training/week). - non-smokers and not regular users of caffeine. - healthy (they do not have kidney, cardiovascular or liver disease) All participants do not : - use food supplements or anti-inflammatory drugs, - take psychotropic drugs or melatonin in the 3 months prior to the study - made trans-meridian journeys in the month prior to the experiment.

Exclusion criteria

Exclusion criteria: the oposite of inclusion criteria

Design outcomes

Primary

MeasureTime frame
biochemical responses (CK, LDH, ASAT, ALAT, CRP);physical performance of the 5mSRT;the circadian variation of the sleep/wake cycle

Secondary

MeasureTime frame
Heart rate (HR);The rate of perceived exertion (RPE) ;Perceived recovery (RPS) ;delayed onset muscle soreness (DOMS) ;Hooper Index;Epworth Sleepness Scale (ESS);visual analogic scale (vas);Subjective Vitality Scale (SVS);Feeling scale;The Brunel Mood Scale (BRUMS);Digit cancellation test

Countries

Tunisia

Contacts

Public ContactIbrahim Ouergui

High Institute of Sport and Physical Education of Kef

ouergui.brahim@yahoo.fr+21697481212

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026